Data / Form D filings / Provista Diagnostics Inc.
Provista Diagnostics Inc.: Form D filings
Provista Diagnostics Inc., a biotechnology company in Scottsdale, AZ, filed 10 Form D notices with the SEC between 2012 and 2018. The latest, on May 22, 2018, reports $2.2 million sold of a $5 million offering to 6 investors.
Find out what Provista Diagnostics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 17301 N. PERIMETER DRIVE, SUITE 100, Scottsdale, AZ, 85255
- Phone
- (602) 224-5500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1539252
The full lists. Form D filings in Arizona: 953 rows, $47.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 22, 2018 | New notice | $5,000,000 | $2,205,633 | $2,794,367 | 6 | May 17, 2018 | sec.gov |
| Sep 15, 2017 | New notice | $4,000,000 | $2,331,084 | $1,668,916 | 28 | Jul 26, 2017 | sec.gov |
| Oct 26, 2016 | New notice | $6,000,000 | $2,564,948 | $3,435,052 | 5 | Oct 13, 2016 | sec.gov |
| Mar 18, 2016 | New notice | $5,100,990 | $5,100,990 | $0 | 25 | Mar 8, 2016 | sec.gov |
| Aug 3, 2015 | New notice | $6,046,254 | $6,046,254 | $0 | 27 | Jul 23, 2015 | sec.gov |
| Mar 16, 2015 | New notice | $3,870,986 | $3,870,986 | $0 | 24 | Feb 17, 2015 | sec.gov |
| Apr 17, 2014 | New notice | $6,000,000 | $6,000,000 | $0 | 34 | Apr 8, 2014 | sec.gov |
| Apr 24, 2013 | New notice | $6,000,000 | $5,999,999 | $1 | 35 | Apr 10, 2013 | sec.gov |
| Sep 21, 2012 | Amendment | $7,485,891 | $7,485,891 | $0 | 32 | Feb 17, 2012 | sec.gov |
| Mar 1, 2012 | New notice | $4,950,000 | $4,510,000 | $440,000 | 18 | Feb 17, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jack J. Levine | Director | |
| John G. Fermanis | Executive Officer | |
| John J. Macaskill | Director | |
| Cynthia E. Collins | Director | |
| John G. Zicarelli | Director | |
| Rao G. Mulpuri | Executive Officer | |
| Robert J. Hariri | Director | |
| Thomas G. Mendell | Director | |
| Gary Altman | Executive Officer, Director | |
| Jeffrey R. Gilman | Director | |
| Yoji G. Nimura | Director | |
| Uriel E. Kusiatin | Executive Officer |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of May 21, 2018 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Provista Diagnostics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.